CA9 and non-small cell lung carcinoma: We analyzed the expression levels of HIF1α, SLC16A3, SLC2A1, LDHA, CA9, and PDK1 in early (stages I–II) and advanced (stages IIIb–IV) NSCLC patients with low or high CD274 expression (Figure 2).